Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions

On 4/8/19 researchers from Azitra, Inc., in collaboration withindependent, nonprofit biomedical research institution The Jackson Laboratory (JAX), announced they have demonstrated the feasibility of engineering a commensal bacterium to deliver a key therapeutic protein to the skin.